Citigroup Inc. Boosts Position in Mettler-Toledo International, Inc. $MTD

Citigroup Inc. raised its position in Mettler-Toledo International, Inc. (NYSE:MTD) by 4.8% during the third quarter, Holdings Channel reports. The fund owned 65,033 shares of the medical instruments supplier’s stock after acquiring an additional 2,989 shares during the period. Citigroup Inc.’s holdings in Mettler-Toledo International were worth $79,835,000 as of its most recent filing with the SEC.

A number of other large investors have also made changes to their positions in MTD. Geneos Wealth Management Inc. lifted its stake in shares of Mettler-Toledo International by 83.3% in the 1st quarter. Geneos Wealth Management Inc. now owns 66 shares of the medical instruments supplier’s stock worth $78,000 after purchasing an additional 30 shares during the period. Asset Management One Co. Ltd. raised its holdings in Mettler-Toledo International by 7.4% in the 2nd quarter. Asset Management One Co. Ltd. now owns 20,401 shares of the medical instruments supplier’s stock worth $23,965,000 after purchasing an additional 1,410 shares during the period. Caitong International Asset Management Co. Ltd bought a new position in Mettler-Toledo International in the 2nd quarter worth $63,000. Sage Mountain Advisors LLC lifted its position in Mettler-Toledo International by 35.6% during the second quarter. Sage Mountain Advisors LLC now owns 244 shares of the medical instruments supplier’s stock valued at $287,000 after purchasing an additional 64 shares in the last quarter. Finally, State of New Jersey Common Pension Fund D grew its holdings in Mettler-Toledo International by 0.6% during the second quarter. State of New Jersey Common Pension Fund D now owns 6,826 shares of the medical instruments supplier’s stock valued at $8,019,000 after purchasing an additional 38 shares during the period. 95.07% of the stock is currently owned by institutional investors.

Mettler-Toledo International Price Performance

NYSE MTD opened at $1,377.04 on Monday. Mettler-Toledo International, Inc. has a 1-year low of $946.69 and a 1-year high of $1,525.17. The business has a 50 day simple moving average of $1,413.42 and a two-hundred day simple moving average of $1,369.50. The stock has a market capitalization of $28.00 billion, a PE ratio of 32.69, a P/E/G ratio of 2.89 and a beta of 1.42.

Mettler-Toledo International (NYSE:MTD) last issued its quarterly earnings data on Thursday, February 5th. The medical instruments supplier reported $13.36 earnings per share (EPS) for the quarter, topping the consensus estimate of $12.76 by $0.60. Mettler-Toledo International had a negative return on equity of 495.07% and a net margin of 21.59%.The business had revenue of $1.13 billion for the quarter, compared to analysts’ expectations of $1.10 billion. During the same period in the prior year, the firm earned $12.41 EPS. The company’s revenue for the quarter was up 8.1% on a year-over-year basis. Mettler-Toledo International has set its Q1 2026 guidance at 8.600-8.750 EPS and its FY 2026 guidance at 46.050-46.700 EPS. On average, analysts anticipate that Mettler-Toledo International, Inc. will post 42.71 EPS for the current fiscal year.

Analyst Ratings Changes

A number of research analysts have recently weighed in on MTD shares. Morgan Stanley lowered their price objective on Mettler-Toledo International from $1,550.00 to $1,475.00 and set an “equal weight” rating on the stock in a research report on Tuesday, February 10th. Wall Street Zen upgraded Mettler-Toledo International from a “hold” rating to a “buy” rating in a research report on Saturday, February 14th. Weiss Ratings reissued a “hold (c+)” rating on shares of Mettler-Toledo International in a report on Monday, December 29th. Bank of America upgraded Mettler-Toledo International from a “neutral” rating to a “buy” rating and set a $1,600.00 price target for the company in a research note on Monday, December 15th. Finally, Stifel Nicolaus boosted their target price on shares of Mettler-Toledo International from $1,450.00 to $1,600.00 and gave the stock a “buy” rating in a report on Monday, November 10th. Six investment analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $1,435.42.

Insider Transactions at Mettler-Toledo International

In other Mettler-Toledo International news, insider La Guerroniere Marc De sold 6,055 shares of the business’s stock in a transaction that occurred on Tuesday, November 25th. The stock was sold at an average price of $1,488.18, for a total transaction of $9,010,929.90. Following the sale, the insider directly owned 187 shares of the company’s stock, valued at $278,289.66. The trade was a 97.00% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CFO Shawn Vadala sold 800 shares of the firm’s stock in a transaction that occurred on Tuesday, February 10th. The shares were sold at an average price of $1,410.12, for a total value of $1,128,096.00. Following the completion of the sale, the chief financial officer directly owned 5,288 shares of the company’s stock, valued at $7,456,714.56. The trade was a 13.14% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders sold 7,855 shares of company stock worth $11,650,026. Insiders own 0.77% of the company’s stock.

About Mettler-Toledo International

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.